The phrase "altered in development" is correct and usable in written English.
It can be used to describe changes or modifications that occur during the process of development, whether in a project, product, or individual growth.
Example: "The software features were altered in development to better meet user needs."
Alternatives: "modified during development" or "changed in the development phase."
When results are considered in the light of molecular studies and studies in which peripheral activity is altered in development, it becomes clear that similar types of changes to the neocortex, such as alterations in cortical field size, can be achieved in more than one way in the developing and evolving neocortex.
This sex difference can be altered in development via the organizational effect of steroid hormones, which determine aspects of the sexual phenotype irrespective of the genetic code carried on the sex chromosomes (cf. Breedlove and Hampson, 2002; Phoenix et al., 1959).
It is well-known that the mechanical properties of these cells are significantly altered in the development and progression of osteoarthritis1,2,3.
Results suggest that opioidergic inhibition of anterior pituitary function is altered in hypertension development.
This analysis provides new insights into the roles of ERBB2, NF1 and TP53, uncovers frequent mutations of the phosphatidylinositol-3-OH kinase regulatory subunit gene PIK3R1, and provides a network view of the pathways altered in the development of glioblastoma.
Among these mutants, 17 were altered in symptom development (data not shown).
Most of the oncogenes known to be altered in OC development have not yet been studied.
The genes EGFR and NF1 in the fourth module are involved in the RTK signaling pathway, which is one of the core pathways altered in the development of GBM [ 2].
These four genes are involved in the RTK/RAS/PI(3)K signaling pathway, which is one of the core pathways altered in the development of glioblastoma and was deduced by the TCGA Research Network [ 2].
Thus, it is feasible to study the whole regulation network of protein expression that is altered in the development of different syndromes described in Uighur medicine to reveal the biological basis of these conditions and discover diagnostic biomarkers.
Despite significant advances in the study of the molecular mechanisms altered in the development and progression of neurodegenerative diseases (NDs), the etiology is still enigmatic and the distinctions between diseases are not always entirely clear.
